Literature DB >> 32289739

Mammary epithelial cell derived exosomal MiR-221 mediates M1 macrophage polarization via SOCS1/STATs to promote inflammatory response.

Mingcheng Cai1, Yu Shi2, Tianhao Zheng2, Shenqiang Hu2, Kun Du2, Anyong Ren2, Xianbo Jia3, Shiyi Chen2, Jie Wang2, Songjia Lai4.   

Abstract

Lactational mastitis seriously alters the normal physiological function of mammary gland and activates the innate immune. Mammary epithelial cells (MECs) secret cytokines and regulate the function of immune system. However, the mechanism MECs mediated crosstalk with immune cells, such as macrophages, during mastitis is unclear. In this study, mouse mammary epithelial cells (HC11), treated with Lipoteichoic acid (LTA), and macrophages (RAW264.7) were used to mimic intercellular communication. Our results showed that exosomal miR-221 level was up-regulated and reached the peak at 12 h after infected by LTA. The expression of miR-211, CD11b protein and TNF-α mRNA were upregulated and the expression of CD206 protein and Arg-1 mRNA were inhibited in RAW264.7 treated with exosomes. In addition, miR-221 mimics and inhibitors enhanced and depressed HC11-derived exosomal miR-221 level, respectively. After treatment of Exo(mimic) in RAW264.7, the expression of CD11b protein and TNF-α mRNA were up-regulated, the expression of CD206 and Arg-1 mRNA were down-regulated. Additionally, Exo(inhibitor) enhanced CD206 protein and Arg-1 mRNA levels and inhibited CD11b protein and TNF-α mRNA levels. Furthermore, SOCS1 was identified to be a target gene of miR-221 by using Luciferase assays. And western blot assays showed that the expression of p-STAT1 and p-STAT3 were elevated and repressed, respectively. Taken together, we suggest that exosomal miR-221 promotes polarization of M1 macrophages via SOCS1, STAT1 and STAT3. And we reveal a novel crosstalk signaling pathway between mammary epithelial cells and macrophages in the process of inflammation.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Exosome; Macrophages; Mammary epithelial cells; Mastitis; miRNAs

Mesh:

Substances:

Year:  2020        PMID: 32289739     DOI: 10.1016/j.intimp.2020.106493

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  6 in total

Review 1.  Extracellular Vesicle/Macrophage Axis: Potential Targets for Inflammatory Disease Intervention.

Authors:  Desheng Tang; Feng Cao; Changsheng Yan; Kun Fang; Jiamin Ma; Lei Gao; Bei Sun; Gang Wang
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

2.  Anti-Tumoral Effect and Action Mechanism of Exosomes Derived From Toxoplasma gondii-Infected Dendritic Cells in Mice Colorectal Cancer.

Authors:  Shilan Zhu; Jinmiao Lu; Zhibing Lin; Asmaa M I Abuzeid; Xiaoyu Chen; Tingting Zhuang; Haiyan Gong; Rongsheng Mi; Yan Huang; Zhaoguo Chen; Guoqing Li
Journal:  Front Oncol       Date:  2022-04-22       Impact factor: 5.738

3.  Synergistic Antibacterial and Anti-inflammatory Activities of Ocimum tenuiflorum Ethanolic Extract against Major Bacterial Mastitis Pathogens.

Authors:  Janejira Srichok; Natthika Yingbun; Teerada Kowawisetsut; Sudsaijai Kornmatitsuk; Uthaiwan Suttisansanee; Piya Temviriyanukul; Boonrat Chantong
Journal:  Antibiotics (Basel)       Date:  2022-04-12

Review 4.  The role of macrophage subtypes and exosomes in immunomodulation.

Authors:  Abdulwahab Teflischi Gharavi; Niloofar Asadi Hanjani; Elaheh Movahed; Mohammad Doroudian
Journal:  Cell Mol Biol Lett       Date:  2022-10-03       Impact factor: 8.702

5.  Diabetes exacerbated sepsis-induced intestinal injury by promoting M1 macrophage polarization via miR-3061/Snail1 signaling.

Authors:  Fang Tan; Yuling Cao; Lei Zheng; Tao Wang; Shuhua Zhao; Jiong Chen; Changji Pang; Weiyi Xia; Zhengyuan Xia; Ningning Li; Xinjin Chi
Journal:  Front Immunol       Date:  2022-09-09       Impact factor: 8.786

6.  Adipocyte-Specific Inhibition of Mir221/222 Ameliorates Diet-Induced Obesity Through Targeting Ddit4.

Authors:  Satoshi Yamaguchi; Dongxiao Zhang; Akihiro Katayama; Naoko Kurooka; Ryosuke Sugawara; Haya Hamed Hassan Albuayjan; Atsuko Nakatsuka; Jun Eguchi; Jun Wada
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-03       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.